MARMIROLI, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 7.846
EU - Europa 3.071
AS - Asia 1.174
AF - Africa 20
SA - Sud America 11
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.134
Nazione #
US - Stati Uniti d'America 7.834
GB - Regno Unito 1.429
IT - Italia 430
SE - Svezia 398
SG - Singapore 331
CN - Cina 325
HK - Hong Kong 287
DE - Germania 241
UA - Ucraina 169
FI - Finlandia 110
TR - Turchia 106
FR - Francia 102
BG - Bulgaria 85
BE - Belgio 34
KR - Corea 34
ID - Indonesia 23
IE - Irlanda 17
VN - Vietnam 14
RU - Federazione Russa 13
IN - India 12
BR - Brasile 8
CA - Canada 8
IR - Iran 8
MY - Malesia 8
NG - Nigeria 8
QA - Qatar 8
NL - Olanda 7
RO - Romania 7
AU - Australia 6
LT - Lituania 5
JP - Giappone 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
ET - Etiopia 3
NO - Norvegia 3
SA - Arabia Saudita 3
TW - Taiwan 3
BZ - Belize 2
CL - Cile 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
GH - Ghana 2
HU - Ungheria 2
MD - Moldavia 2
PK - Pakistan 2
UG - Uganda 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IL - Israele 1
LB - Libano 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
RS - Serbia 1
Totale 12.134
Città #
Southend 1.257
Fairfield 1.195
Woodbridge 728
Ashburn 594
Santa Clara 543
Houston 522
Chandler 505
Seattle 464
Cambridge 386
Wilmington 381
Jacksonville 360
Ann Arbor 320
Dearborn 306
Hong Kong 284
Singapore 247
Nyköping 213
San Diego 136
Modena 121
Beijing 95
Princeton 89
Sofia 85
Eugene 67
Izmir 57
Des Moines 55
Helsinki 50
London 35
Bologna 34
Shanghai 32
New York 31
Redwood City 27
Grafing 26
Boardman 23
Jakarta 23
Fremont 22
Milan 21
Ghent 20
Bremen 19
Hefei 19
Falls Church 18
Frankfurt am Main 17
Dublin 16
Norwalk 14
Brussels 13
Dong Ket 13
Rome 12
Phoenix 10
Hounslow 9
Chiswick 8
Doha 8
Frattamaggiore 8
Padova 8
Acton 7
Chicago 7
Kunming 7
Auburn Hills 6
Augusta 6
Guangzhou 6
Kilburn 6
Nanjing 6
San Jose 6
São Paulo 6
Bari 5
Jinan 5
Monmouth Junction 5
Munich 5
Verona 5
Chongqing 4
Florence 4
Fort Worth 4
Indiana 4
Leawood 4
Los Angeles 4
Nanterre 4
Port Harcourt 4
Segrate 4
Shenyang 4
Toronto 4
Wuhan 4
Ardabil 3
Berlin 3
Birmingham 3
Brescello 3
Crotone 3
Dongguan 3
Edinburgh 3
Formigine 3
Harar 3
Ibadan 3
Kuala Lumpur 3
Lappeenranta 3
Lisbon 3
Nanchang 3
Piacenza 3
Pieve di Soligo 3
Prescot 3
Roncoferraro 3
San Francisco 3
Stockholm 3
Taipei 3
Tokyo 3
Totale 9.748
Nome #
Development of solvent-casting particulate leaching (SCPL) polymer scaffolds as improved three-dimensional supports to mimic the bone marrow niche 338
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 294
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 267
Risk Assessment for Metals and PAHs by Mediterranean Seafood 244
The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression 236
AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation 228
Phosphorylation, Signaling, and Cancer: Targets and Targeting 226
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 226
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 216
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 216
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 211
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 209
Serum fatty acids and risk of cutaneous melanoma: a population-based case-control study 207
Cross-talk between the CK2 and AKT signaling pathways in cancer 204
Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics 202
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 200
Ankrd2/ARPP is a novel Akt2 specific substrate andregulates myogenic differentiation upon cellular exposure to H(2)O(2). 198
MATER protein as substrate of PKCepsilon in human cumulus cells. 197
Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging 196
A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward 188
Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. 188
Reverse-phase protein microarrays (RPPA) as a diagnosticand therapeutic guide in multidrug resistant leukemia 180
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 177
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? 174
Human MATER localization in specific cell domains of oocytes and follicular cells 173
Signaling specificity in the Akt pathway in biology and disease 172
The need for a reassessment of the safe upper limit of selenium in drinking water 162
Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase 160
Targeting of the Akt/PKB kinase to the actin skeleton 160
Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cells. 160
At the nucleus of the problem: Nuclear proteins and disease 159
Phosphoinositidase C isozymes in SaOS-2 cells: immunocytochemical detection in nuclear and cytoplasmic compartments. 159
Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth. 158
Inhibition of Ras-mediated signaling pathways in CML stem cells 158
Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. 158
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level 157
Laminopathies and A-type lamin-associated signalling pathways 157
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 156
Phosphatidylinositol 3-kinase translocation to the nucleus is an early event in the interleukin-1 signalling mechanism in human osteosarcoma Saos-2 cells. 155
Nuclear damages and oxidative stress: new perspectives for laminopathies 153
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells 151
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS. 151
Nuclear lipid-dependent signal transduction in human osteosarcoma cells. 149
Melanocytes – A novel tool to study mitochondrial dysfunction in Duchenne Muscular Dystrophy 149
Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity inBoth p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibitingthe Akt Pathway 147
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 147
Tiazofurin induces a down modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. 146
Lamin A Ser404 Is a Nuclear Target of Akt Phosphorylation in C2C12 Cells 145
New roles for lamins, nuclear envelope proteins and actin in the nucleus 144
Nuclear protein kinases in rat liver: evidence for increased Histone H1 phosphorylating activity during liver regeneration. 143
Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy 141
Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. 140
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer 138
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 137
Inhibition of phosphoinositide 3-kinase impairs pre-commitment cell cycle traverse and prevents differentiation in erythroleukaemia cells. 133
Age-related events in human active T limphocytes. Changes in the phosphoinositidase C activity. 129
Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit. 128
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 115
Interleukin-1alfa stimulates nuclear phosphoinositidase C activity in human osteosarcoma SaOS-2 cells. 107
Transfected Saos-2 cells overexpressing phosphoinositidase C beta1 isoform accumulate it within the nucleus. 105
The intranuclear amount of phospholipase C beta1 decreases following cell differentiation in Friend cells, whereas gamma1 isoform is not affected. 102
Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells 102
Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappa B transactivation in Saos2 cells requires the Akt/protein kinase B kinase 96
Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts 96
Nuclear PLCβ1 acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells 96
An unbiased approach to mapping the signaling network of the pseudorabies virus US3 protein 96
Troglitazione affects survival of human osteosarcoma cells 95
Unusual laminin alpha2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy. 94
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence. 80
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 74
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 67
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival 59
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 49
Stabilization of ornithine decarboxylase in erythroleukemia cells depleted of ATP 48
Mechanisms involved in the promoting activity of fibroblasts in HTLV-1-mediated lymphomagenesis: Insights into the plasticity of lymphomatous cells 48
IL-1 receptor signalling mechanism in SAOS-2 osteosarcoma cells 46
A different involvement of polyamines in the induction of tyrosine aminotransferase by glucagon, isoproterenol or serum in cultured heart cells 44
Phosphorylation of ornithine decarboxylase in intact erythroleukemia cells 44
Effect of ATP depletion and phenanthroline on the spermidine-mediated decay of ornithine decarboxylase in erythroleukemia cells 44
Effect of sodium arsentie on the induction and turnover of ornithine decarboxylase activity in erythroleukemia cells 43
Study on the role of endogenous polyamines in glucagon, isoproterenol or serum-mediated induction of tyrosine aminotransferase in cultured heart cells 41
The key role of public health in renovating Italian biomedical doctoral programs 40
Inositol lipid phosphorylation and breakdown in rat liver nuclei is affected by hydrocortisone blood levels 39
Involvement of thiol transferase- and thioredoxin-dependent systems in the protection of 'essential' thiol groups of ornithine decarboxylase 39
Inhibition of rat heart ornithine decarboxylase by basic polypeptides 38
Immunocytochemical detection of the specific association of different PIC isoforms with cytoskeletal and nuclear matrix compartments in PC12 cells 36
Editor's Note: Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway 35
Regulation of hormonal sensitivity of cardiac cells in culture by polyamines 31
Totale 12.246
Categoria #
all - tutte 63.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.884 0 0 0 0 361 362 393 231 215 95 125 102
2020/20212.172 142 90 143 185 263 177 168 250 92 364 191 107
2021/20221.863 71 226 215 147 28 83 127 116 142 122 430 156
2022/20231.469 175 145 129 118 158 225 34 150 210 5 62 58
2023/20241.044 37 45 52 128 209 77 146 133 43 27 36 111
2024/2025956 97 32 48 205 574 0 0 0 0 0 0 0
Totale 12.246